First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2
Authors:
Open Access
- 18 January 2023
- journal article
- research article
- Published by Elsevier in The Lancet Microbe
- Vol. 4 (3) , e140-e148
Abstract
No abstract availableKeywords
Funding Information
- Horizon 2020 Framework Programme
- European Commission (H2020-SC1-PHE-CORONAVIRUS-2020)
- Carlsbergfondet
- Novo Nordisk Foundation
This publication has 30 references indexed in Scilit:
- A Review of Clinical Trials of Human Papillomavirus Prophylactic VaccinesVaccine, 2012
- Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesinProceedings of the National Academy of Sciences, 2012
- Vaccine delivery: a matter of size, geometry, kinetics and molecular patternsNature Reviews Immunology, 2010
- Safety and immunogenicity of GMZ2 — a MSP3–GLURP fusion protein malaria vaccine candidateVaccine, 2009
- Basal cell carcinomas arising in travel vaccination scarsClinical and Experimental Dermatology, 2008
- Nonmelanoma skin cancer in the United States: IncidenceJournal of the American Academy of Dermatology, 1994
- The validity and practicality of sun-reactive skin types I through VIArchives of Dermatology, 1988
- The Validity and Practicality of Sun-Reactive Skin Types I Through VIArchives of Dermatology, 1988
- Basal cell carcinoma arising in a smallpox vaccination site.Journal of Clinical Pathology, 1980
- Basal Cell Carcinoma following BCG VaccinationDiseases of the Chest, 1963